Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by gamma-radiolysis of ethanol-water mixtures. 1998

A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
Laboratoire de Bio-Gérontologie, Centre de Recherche en Gérontologie, Institut Universitaire de Gériatrie, Sherbrooke, Québec, Canada.

Oxidized low density lipoproteins (LDL) are believed to play a central role in the events that initiate atherosclerosis. Antioxidants have been shown to decrease the oxidation of LDL, leading to the diminution of atherosclerosis. Since it is well-known that decreased levels of dehydroepiandrosterone (DHEA) are linked to the development of atherosclerosis, we studied the modulation of the oxidation of LDL by DHEA. LDL were obtained from 10 healthy subjects and oxidized by free radicals produced by gamma-radiolysis of ethanol-water mixtures. The formation of conjugated dienes and thiobarbituric acid-reactive substances (TBARS), the vitamin E content, as well as the incorporation of 4-[14C]DHEA in LDL and the chemotactic effect of oxidized LDL in the presence of DHEA towards monocytes, were investigated. It was found that DHEA was able to inhibit the oxidation of LDL by reducing over 90% of the conjugated dienes and TBARS formation, as well as by reducing the vitamin E disappearance and significantly decreasing the chemotactic activity towards monocytes. Our results suggest that DHEA exerts its antioxidative effect by protecting the endogenous vitamin E of LDL.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol

Related Publications

A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
June 1993, Radiation research,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
February 1996, The Biochemical journal,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
November 1992, Radiation research,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
February 2001, Radiation research,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
January 1994, Drugs under experimental and clinical research,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
October 1993, Bulletin de l'Academie nationale de medecine,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
April 1994, Giornale italiano di cardiologia,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
January 1992, International journal of tissue reactions,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
September 2000, Atherosclerosis,
A Khalil, and J G Lehoux, and R J Wagner, and O Lesur, and S Cruz, and E Dupont, and J P Jay-Gerin, and J Wallach, and T Fülöp
January 1999, Life sciences,
Copied contents to your clipboard!